SAB Biotherapeutics Inc (SABS) — Net Asset Quality Index
SAB Biotherapeutics Inc (SABS) has a Net Asset Quality Index of 87.7% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $172.81 Million minus total liabilities of $21.32 Million yields net assets of $151.49 Million. A higher index indicates a stronger, lower-leverage balance sheet. See SAB Biotherapeutics Inc liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
SAB Biotherapeutics Inc Net Asset Quality Index Over Time (2019–2025)
This chart shows how SAB Biotherapeutics Inc's Net Asset Quality Index has evolved across 7 annual periods from 2019 to 2025. As of December 2025, the index stands at 87.7%, representing net assets of $151.49 Million against total assets of $172.81 Million USD. Explore SAB Biotherapeutics Inc (SABS) cash flow conversion to assess how effectively this company generates cash.
Annual Net Asset Quality Index for SAB Biotherapeutics Inc (2019–2025)
The table below presents the year-by-year Net Asset Quality Index for SAB Biotherapeutics Inc from 2019 to 2025, covering 7 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see how much is SAB Biotherapeutics Inc worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 87.7% | $151.49 Million | $172.81 Million | $21.32 Million | ▲ +28.9 pp |
| 2024 | 58.8% | $25.97 Million | $44.20 Million | $18.23 Million | ▼ -9.5 pp |
| 2023 | 68.3% | $57.30 Million | $83.94 Million | $26.64 Million | ▲ +7.2 pp |
| 2022 | 61.0% | $31.06 Million | $50.90 Million | $19.85 Million | ▲ +13.5 pp |
| 2021 | 47.5% | $38.55 Million | $81.14 Million | $42.59 Million | ▼ -21.5 pp |
| 2020 | 69.0% | $39.01 Million | $56.54 Million | $17.53 Million | ▲ +81.8 pp |
| 2019 | -12.8% | $-2.31 Million | $18.00 Million | $20.31 Million | — |